Article

Managing highly distorted corneas with topography-guided treatment

Final results from a randomized, prospective comparison of advanced surface ablation (ASA) and sub-Bowman's keratomileusis (SBK) for low-to-moderate myopia show SBK affords much faster visual recovery. By 12 months, however, both procedures are associated with similarly excellent efficacy and safety, said Capt. Steven C. Schallhorn, MD, at Refractive Surgery Subspecialty Day.

Topography-guided LASIK, used with a comprehensive eye scanner (Pentacam, Oculus), has been very successful in minimizing severe corneal distortions and offers reliable registration in most cases, according to John Kanellopoulos, MD, in private practice in New York City and Athens.

Dr. Kanellopoulos has been using topography-guided software (Allegretto Wave Topolyzer, WaveLight) for 5 years at his clinic in Athens to treat extreme primary and surgery-induced irregularities.

This experience has taught Dr. Kanellopoulos that topography-guided customized ablation may require nomogram manipulation to adjust sphere, as the topographer does not read the refractive error in the eye. He and his colleagues also have found that corneal cross-linking either before or after the procedure may be effective in stabilizing the iatrogenic ectasias of keratoconus and, in the future, may reduce the number of transplants necessary to treat keratoconus.

Dr. Kanellopoulos has used topography-guided custom ablation in cases such as enlargement of the optical zone in re-treatment of residual hyperopia and severe irregularities caused by contact lens scarring. The technique was also used in an eye that had undergone four LASIK recuts, one of which may have resulted in loss of a corneal sliver. In this instance, Dr. Kanellopoulos performed topography-guided PRK.

While it seems to be safe and effective, topography-guided ablation also is likely to raise debates about when it is most appropriately used.

"For someone who has this technology available to them, there are ethical questions such as whether there will be treatment of early ectasias in order to avoid a corneal transplant in the future," Dr. Kanellopoulos said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.